Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

The Current Status of RAS Testing in Colorectal Cancer

February 26th 2016

Colorectal Cancer: Challenges in Next-Generation Sequencing

February 26th 2016

Practical Considerations in Molecular Testing in CRC

February 26th 2016

Prognostic and Predictive Markers in Colorectal Cancer

February 26th 2016

Salvage Therapy and Emerging Agents in Colorectal Cancer

February 25th 2016

Jennifer Wu, MD, reviews recently approved agents in refractory colorectal cancer, as well as biomarker-directed emerging therapies in the setting.

Dr. Wiesner on Benefits of Genetic Testing in Colorectal Cancer

February 24th 2016

Georgia L. Wiesner, MD, MS, director, Clinical and Translational Hereditary Cancer Program, Ingram Professor of Cancer Research, professor of Medicine, cancer geneticist, Vanderbilt-Ingram Cancer Center, explains the benefits of genetic testing for colorectal cancer (CRC) and how oncologists can discuss it with their patients.

Genomic Complexity Stifles Targeted Advances in Colorectal Cancer

February 16th 2016

Experts in the field assert that the path forward requires a paradigm shift toward integrative analyses that encompass multiple classes of genomic aberrations and consensus classification of CRC based on genomic data to facilitate more effective management of this disease.

Advanced Pancreatic Cancer: A Look Ahead

February 15th 2016

Early Phase Clinical Trials in Pancreatic Cancer

February 15th 2016

Molecular Profiling in Pancreatic Cancer

February 15th 2016

Emerging Immunotherapy Data in Pancreatic Cancer

February 15th 2016

Advanced Pancreatic Cancer: Options in the Adjuvant Setting

February 15th 2016

Neoadjuvant Therapy in Resectable Pancreatic Cancer

February 15th 2016

Role of Surgery in Locally Advanced Pancreatic Cancer

February 15th 2016

QOL Considerations in Advanced Pancreatic Cancer

February 15th 2016

Impact of MM-398 on Sequencing Decisions in Pancreatic Cancer

February 15th 2016

Clinical Trial Results of MM-398 in Pancreatic Cancer

February 15th 2016

Dose Modification Rationale in Advanced Pancreatic Cancer

February 15th 2016

Deciding Among Frontline Standards of Care in Pancreatic Cancer

February 15th 2016

Systemic Therapy in Newly Diagnosed Pancreatic Cancer

February 15th 2016